Myriad Genetics | MYGN - Ativos





Ativos Alterar Data
Agilent USD 13.07B 252M 2026-03
Becton, Dickinson and Co. USD 50.83B 4.01B 2026-03
Bio-Rad Laboratories USD 9.79B 786.5M 2026-03
Bruker USD 6.13B 110.7M 2026-03
Danaher USD 83.54B 80M 2026-03
Illumina USD 6.56B 85M 2026-03
J&J USD 200.89B 1.68B 2026-03
Mettler Toledo International USD 3.67B 43.73M 2026-03
Myriad Genetics USD 673.7M 32.9M 2026-03
OraSure Technologies USD 379.17M 24M 2026-03
Pacific Biosciences Of California USD 782.36M 1.72M 2026-03
Quest Diagnostics USD 16.67B 448M 2026-03
Quidel USD 5.63B 140.6M 2026-03
Repligen USD 2.93B 18.93M 2026-03
Revvity USD 12B 171.82M 2026-03
Standard Biotools USD 639.11M 71.36M 2026-03
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
Veracyte USD 1.44B 30.38M 2026-03
Waters USD 24.53B 19.45B 2026-03